UNSPSC 51391503: Naminterol

This classification denotes a beta-adrenergic agonist with the molecular formula C19H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1Q13LFM3WG, chemically known as 5-amino-alpha-(((p-methoxy-alpha-methylphenethyl)amino)methyl)-m-xylene-alpha,alpha-diol but generally known as naminterol, which bears US NIH Compound Identifier 174101. European Medicines Agency schedules Naminterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09144MIG.

UNSPSC 51391503 Naminterol is a Commodity code that covers the procurement of naloxone and related emergency pharmaceutical products and drug deactivation systems for community health and public safety applications. State and local governments buy these products through this code to support opioid overdose response initiatives and controlled substance disposal programs. The issuing bodies include county health departments and state health and human services agencies, which procure naloxone in bulk quantities alongside complementary drug disposal or deactivation systems. These purchases typically involve multi-year supply agreements with quarterly or regular delivery schedules to designated health facilities or distribution centers.

Recent activity shows procurement concentrated in the Southeast and South, with Seminole County, Florida issuing IFB 60459723LAS in June 2026 to acquire 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with a July 26, 2023 response deadline, and the Texas Health and Human Services Commission posting RFI HHS0017013 in April 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program that would inform future formal solicitations. The Seminole County procurement specifies quarterly deliveries to its Community Health Building with vendor responsibility for shipping and delivery costs, a two-year initial term with one-year renewal option, and compliance requirements including E-Verify, drug-free workplace certification, and federal compliance standards tied to potential FEMA funding.